Zyprexa quotes
Zyprexa

Eli Lilly killed 200,000 people with Zyprexa. [2014] Get Real: Peter Gøtzsche Responds 

In clinical trials averaging 6 weeks, Zyprexa was tested in 2,500 adults. The drug was linked to serious, in some cases life-threatening side effects requiring hospitalization in 22% of those tested.... During those 6 week clinical trials there were 20 deaths, of which 12 were suicides. [Nov 2004] Eli Lilly’s highly touted new anti-psychotic, Zyprexa

In fact, I think the newer drugs will eventually be seen as more dangerous than the old drugs, if that's possible. As you know, the standard neuroleptics like Thorazine and Haldol have had quite a litany of harm with the tardive dyskinesia and all.
    So when we got the new atypical drugs, they were touted as so much safer. But with these new atypicals, you get all sorts of metabolic dysfunctions.
    Let's talk about Zyprexa. It has a different profile. So it may not cause as much tardive dyskinesia. It may not cause as many Parkinsonian symptoms. But it causes a whole range of new symptoms. So, for example, it's more likely to cause diabetes. It's more likely to cause pancreatic disorders. It's more likely to cause obesity and appetite-disregulation disorders.
    In fact, researchers in Ireland reported in 2003 that since the introduction of the atypical antipsychotics, the death rate among people with schizophrenia has doubled. They have done death rates of people treated with standard neuroleptics and then they compare that with death rates of people treated with atypical antipsychotics, and it doubles. It doubles! It didn't reduce harm. In fact, in their seven-year study, 25 of the 72 patients died.
    You're getting respiratory problems, you're getting people dying of incredibly high cholesterol counts, heart problems, diabetes. With olanzapine (Zyprexa), one of the problems is that you're really screwing up the core metabolic system. That's why you get these huge weight gains, and you get the diabetes. Zyprexa basically disrupts the machine that we are that processes food and extracts energy from that food. So this very fundamental thing that we humans do is disrupted, and at some point you just see all these pancreatic problems, faulty glucose regulation, diabetes, etc. That's really a sign that you're mucking with something very fundamental to life Psychiatric Drugs: An Assault on the Human Condition Street Spirit Interview with Robert Whitaker

A couple things to know about the new drugs, the atypicals. First of all, the clinical trials to test them were totally bogus. They were designed to make the old drugs look bad and the new drugs look good. That's coming out now, the fact that these studies painted an exaggerated picture of the atypicals. They may be no more efficacious and they may have just as many side-effects as the older neuroleptics. So that tells you there's plenty of reason to worry. Now that we've had them out for eight to ten years, we're finding out all sorts of problems.  
    The good story is that in some instances they're using lower dosages of these atypicals, and because they're using lower dosages, people are finding them less problematic. They don't clamp down as strongly on the dopamine system as the old drugs. So that's good and hopeful.
    The negative part is this: They've clearly lied about what these drugs do. They're powerful drugs and they work on a number of neurotransmitter systems. And they clearly are problematic. With olanzapine [marketed as Zyprexa], you're going to see that. Just as tardive dyskinesia was lying in wait all the time with the standard neuroleptics, diabetes is there with olanzapine, big time. And diabetes is a life-threatening, life-shortening disease. So you give that drug to a 12-year-old, a 15-year-old, an 18-year-old and they develop diabetes and 80 pounds of weight gain -- that is a very harmful thing. [Interview 2005] Psychiatry's Untold History of Cruelty, Torture, Eugenics and Brain Damage